Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity

Cinzia Borghese, Lara Cattaruzza, Eliana Pivetta, Nicola Normanno, Antonella De Luca, Mario Mazzucato, Marta Celegato, Alfonso Colombatti, Donatella Aldinucci

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds